Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Med Clin (Barc) ; 124(18): 692-4, 2005 May 14.
Article in Spanish | MEDLINE | ID: mdl-15899164

ABSTRACT

BACKGROUND AND OBJECTIVE: Troponins are useful tools in management of patients with acute coronary syndrome (ACS). Small increases do not guarantee a desirable precision (CV < 10%) and there is a "grey zone" between 99 percentile and clinical cut off. Our objective was to evaluate if "grey zone" troponin values reflect heart damage or they are only "analyzer noise". PATIENTS AND METHOD: Final diagnoses of patients with "grey zone" values attended during 2001 and 2002 were reviewed (group Tn). Control group (Cn): patients with negative values (four months randomly chosen during the same period). Admitted patients were classified in: A, ACS; B, non ischemic heart disease, and C, non heart disease. RESULTS: Tn group (n = 521): admitted, 330 (63.3%); A (53.9%), B (30.9%), C (15.2%). Cn group (n = 652): admitted, 156 (23.9%); A (41%), B (24.4%), C (34.6%). Odds ratio for admittance (Tn vs Cn) was 4.82 (95% CI, 3.68-6.31); OR for diagnosis A, B and C (Tn vs Cn) were: A (1.56) (95% CI, 1.04-2.34), B (1.43) (95% CI, 0.90-2.25), C (0.38) (95% CI, 0.24-0.6). CONCLUSIONS: Intermediate troponin values are associated with diagnosis of heart disease, especially ACS.


Subject(s)
Angina Pectoris/blood , Heart Diseases/blood , Troponin T/blood , Aged , Biomarkers/blood , Female , Humans , Male , Middle Aged , Myocardial Infarction/blood
2.
Med. clín (Ed. impr.) ; 124(18): 692-694, mayo 2005. tab
Article in Es | IBECS | ID: ibc-036604

ABSTRACT

FUNDAMENTO Y OBJETIVO: Las troponinas son útiles en el diagnóstico del síndrome coronario agudo (SCA). Pequeños incrementos no garantizan la imprecisión recomendable (CV < 10%).Así, existe una «zona gris» de valores intermedios entre el valor superior de la normalidad yel punto de corte de decisión clínica. Evaluamos si estos valores de cTnT reflejan lesión miocárdica o son «ruido» del analizador. PACIENTES Y MÉTODO: Estudiamos a pacientes de urgencias con valores intermedios de cTnT durante 2001-2002 (grupo Tn). Grupo control (Cn): muestra de pacientes del mismo período con cTnT negativa. Grupos diagnósticos finales: A, relacionados con SCA; B, relacionados con patología cardíaca no isquémica; C, enfermedades no cardíacas. RESULTADOS: Grupo Tn (n = 521): ingresos, 330(63,3%); A (53,9%), B (30,9%), C (15,2%).Grupo Cn (n = 652): ingresos, 156 (23,9%); A(41%), B (24,4%), C (34,6%). Odds ratio para ingresos en grupo Tn frente al Cn, 4,82 (IC del95%, 3,68-6,31); para los diagnósticos: A 1,56(IC del 95%, 1,04-2,34), B 1,43 (IC del 95%,0,90-2,25), C 0,38 (IC del 95%, 0,24-0,6).CONCLUSIONES: Los valores intermedios de cTnT se asocian con patología cardíaca, especialmente SCA


BACKGROUND AND OBJECTIVE: Troponins are useful tools in management of patients with acute coronary syndrome (ACS). Small increases do not guarantee a desirable precision (CV < 10%) and there is a «grey zone» between 99 percentile and clinical cut off. Our objective was to evaluate if «grey zone» troponin values reflect heart damage or they are only «analyzer noise». PATIENTS AND METHOD: Final diagnoses of patients with «grey zone» values attended during2001 and 2002 were reviewed (group Tn).Control group (Cn): patients with negative values(four months randomly chosen during the same period). Admitted patients were classifiedin: A, ACS; B, non ischemic heart disease, and C, non heart disease. RESULTS: Tn group (n = 521): admitted, 330(63.3%); A (53.9%), B (30.9%), C (15.2%).Cn group (n = 652): admitted, 156 (23.9%);A (41%), B (24.4%), C (34.6%). Odds ratio for admittance (Tn vs Cn) was 4.82 (95% CI,3.68-6.31); OR for diagnosis A, B and C (Tnvs Cn) were: A (1.56) (95% CI, 1.04-2.34), B(1.43) (95% CI, 0.90-2.25), C (0.38) (95%CI, 0.24-0.6).CONCLUSIONS: Intermediate troponin values are associated with diagnosis of heart disease, especially ACS


Subject(s)
Humans , Troponin T/analysis , Coronary Disease/diagnosis , Biomarkers/analysis , Diagnosis, Differential , Risk Factors , Case-Control Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...